In recent trading session, Protagenic Therapeutics Inc (NASDAQ:PTIX) saw 0.43 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $0.27 trading at $0.0 or -1.17% at last check today assigns it a market valuation of $1.96M. That most recent trading price of PTIX’s stock is at a discount of -592.59% from its 52-week high price of $1.87 and is indicating a premium of 11.11% from its 52-week low price of $0.24. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 11.0 million shares which gives us an average trading volume of 2.21 million if we extend that period to 3-months.

Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information

Upright in the red during last session for losing -1.17%, in the last five days PTIX remained trading in the red while hitting it’s week-highest on Friday, 03/07/25 when the stock touched $0.27 price level, adding 31.0% to its value on the day. Protagenic Therapeutics Inc’s shares saw a change of -44.71% in year-to-date performance and have moved -25.82% in past 5-day. Protagenic Therapeutics Inc (NASDAQ:PTIX) showed a performance of 0.86% in past 30-days. Number of shares sold short was 0.12 million shares which calculate 0.23 days to cover the short interests.

Protagenic Therapeutics Inc (NASDAQ:PTIX)’s Major holders

Insiders are in possession of 13.43% of company’s total shares while institution are holding 5.38 percent of that, with stock having share float percentage of 6.22%. Investors also watch the number of corporate investors in a company very closely, which is 5.38% institutions for Protagenic Therapeutics Inc that are currently holding shares of the company.

On the other hand, Vanguard Extended Market Index Fund and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 32.0 shares of worth $8875.0 or 0.44% of the total outstanding shares. The later fund manager was in possession of 22.88 shares on Dec 31, 2024 , making its stake of worth around $6347.0 in the company or a holder of 0.32% of company’s stock.